FDA Drugs (New Approvals & NDA)Original article
Bioactive Services USA, LLC / Herstat Inc. - 734784 - 10/01/2026
RegulatoryNegative
AI Analysis
Summary
Bioactive Services USA, LLC and Herstat Inc. have been identified as distributors of unapproved new drugs by the FDA. This is a routine regulatory enforcement notice with limited material impact.
Outcome Details
Unapproved new drugs identified
Importance:3/10
Sentiment:
-0.50
unapproved drugsregulatory actionFDA enforcement
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on October 6, 2026 1:21 PM